支气管扩张症中气道阻塞的可逆性
Reversibility of airways obstruction in bronchiectasis.
作者信息
Nogrady S G, Evans W V, Davies B H
出版信息
Thorax. 1978 Oct;33(5):635-7. doi: 10.1136/thx.33.5.635.
Abstract
Patients with airways obstruction and bronchiectasis were investigated for features of allergic disease and for reversibility of airways obstruction in respinse to inhaled and intravenous salbutamol. There was a 26% increase in PEFR and a 16% increase in FEV1 after inhaled salbutamol, and the response to the intravenous drug was not significantly better than that to the inhaled. Those patients who responded to bronchodilators could not be identified by clinical or immunological features.
摘要
对患有气道阻塞和支气管扩张的患者进行了过敏性疾病特征以及气道阻塞对吸入和静脉注射沙丁胺醇反应的可逆性研究。吸入沙丁胺醇后，呼气峰值流速（PEFR）增加了26%，第一秒用力呼气容积（FEV1）增加了16%，且静脉注射药物的反应并不比吸入药物的反应显著更好。那些对支气管扩张剂有反应的患者无法通过临床或免疫学特征来识别。
相似文献
1
Reversibility of airways obstruction in bronchiectasis.支气管扩张症中气道阻塞的可逆性
Thorax. 1978 Oct;33(5):635-7. doi: 10.1136/thx.33.5.635.
2
Airway obstruction in bronchiectasis and its reversibility--a study of 38 patients.
Indian J Chest Dis Allied Sci. 1992 Jan-Mar;34(1):7-10.
3
A comparative trial of combination therapy in obstructive airways disease.
Curr Med Res Opin. 1980;7(1):23-7. doi: 10.1185/03007998009116510.
4
Comparison of salmefamol and salbutamol in patients with chronic airways obstruction.沙美特罗与沙丁胺醇对慢性气道阻塞患者疗效的比较。
Br J Clin Pharmacol. 1976 Feb;3(1):151-5. doi: 10.1111/j.1365-2125.1976.tb00582.x.
5
Reversible airway obstruction in rheumatic mitral valve disease.
Respirology. 1998 Mar;3(1):25-31. doi: 10.1046/j.1440-1843.1998.d01-4.x.
6
Effect of salbutamol on the measurement of single-breath diffusing capacity.沙丁胺醇对单次呼吸弥散量测定的影响。
Respirology. 2013 Nov;18(8):1223-9. doi: 10.1111/resp.12125.
7
Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway calibre.慢性气流阻塞患者对支气管扩张剂反应的可逆性测量：与气道口径的关系
Thorax. 1991 Jan;46(1):43-5. doi: 10.1136/thx.46.1.43.
8
A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction.吸入用克仑特罗与沙丁胺醇治疗伴有可逆性气道阻塞的慢性支气管炎的比较
Eur J Respir Dis. 1980 Jun;61(3):143-50.
9
Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'.长期哮喘患者的气道阻塞符合“不可逆性哮喘”。
Chest. 1997 Nov 5;112(5):1234-40. doi: 10.1378/chest.112.5.1234.
10
[The bronchodilator effect of aerosol beta-2-mimetic and anticholinergic agents in patients with chronic bronchitis].
Rev Mal Respir. 1990;7(1):59-63.
引用本文的文献
1
The Prevalence of Bronchodilator Responsiveness "Asthma" Among Adult Indigenous Australians Referred for Lung Function Testing in the Top End Northern Territory of Australia.在澳大利亚北领地顶端地区接受肺功能测试的成年澳大利亚原住民中，支气管扩张剂反应性“哮喘”的患病率
J Asthma Allergy. 2022 Sep 14;15:1305-1319. doi: 10.2147/JAA.S376213. eCollection 2022.
2
Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis.支气管扩张症成人患者支气管舒张剂的作用机制及临床应用
Drugs. 2022 Jan;82(1):1-13. doi: 10.1007/s40265-021-01646-3. Epub 2021 Nov 26.
3
The impact of intravenous dobutamine on spirometry with bronchodilator test.静脉注射多巴酚丁胺对支气管扩张试验肺量计检查结果的影响
Respir Med Case Rep. 2020 Oct 15;31:101264. doi: 10.1016/j.rmcr.2020.101264. eCollection 2020.
4
Primary care implications of the British Thoracic Society Guidelines for bronchiectasis in adults 2019.英国胸科学会成人支气管扩张症指南 2019 年版的初级保健意义。
NPJ Prim Care Respir Med. 2019 Jun 27;29(1):24. doi: 10.1038/s41533-019-0136-8.
5
The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis.沙特胸科学会非囊性纤维化支气管扩张症诊断与管理指南
Ann Thorac Med. 2017 Jul-Sep;12(3):135-161. doi: 10.4103/atm.ATM_171_17.
6
Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline.基于基线支气管扩张剂反应的长期支气管扩张剂对气流受限支气管扩张症患者的影响
Int J Chron Obstruct Pulmon Dis. 2016 Nov 7;11:2757-2764. doi: 10.2147/COPD.S115581. eCollection 2016.
7
Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis.高频胸壁振荡治疗支气管扩张症患者的疗效。
BMC Pulm Med. 2013 Apr 4;13:21. doi: 10.1186/1471-2466-13-21.
8
Effect of obstructive airway disease in patients with non-cystic fibrosis bronchiectasis.阻塞性气道疾病对非囊性纤维化支气管扩张症患者的影响。
Ann Saudi Med. 2004 Jul-Aug;24(4):284-7. doi: 10.5144/0256-4947.2004.284.
9
Atopy, immunological changes, and respiratory function in bronchiectasis.支气管扩张症中的特应性、免疫变化及呼吸功能
Thorax. 1984 Mar;39(3):179-84. doi: 10.1136/thx.39.3.179.
10
Bronchiectasis, congenital and acquired.支气管扩张症，先天性和后天性的。
Br Med J. 1979 May 26;1(6175):1380.
本文引用的文献
1
THE SPUTUM IN BRONCHIAL ASTHMA: PATHOGNOMONIC PATTERNS.支气管哮喘中的痰液：特征性模式。
J Pathol Bacteriol. 1965 Apr;89:535-41.
2
Forced expiratory volume before and after isoprenaline.异丙肾上腺素前后的用力呼气量
Thorax. 1957 Sep;12(3):276-8. doi: 10.1136/thx.12.3.276.
3
Factors associated with respiratory insufficiency in bronchiectasis.支气管扩张症中与呼吸功能不全相关的因素。
Am J Med. 1966 Oct;41(4):562-71. doi: 10.1016/0002-9343(66)90218-x.
4
Pulmonary ventilation and gas exchange in bronchiectasis.支气管扩张症中的肺通气与气体交换
Thorax. 1971 Nov;26(6):727-33. doi: 10.1136/thx.26.6.727.
Zotero 插件